| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

( Fels Research Institute, Temple University School of Medicine, Philadelphia, Pennsylvania)
Norethynodrel with mestranol (Enovid) fed to female Wistar rats, 3 mg. 6 times per week for up to 50 weeks, produced no neoplasms of the breast or other tissues and did not enhance or retard mammary carcinogenesis evoked by gastric instillations of 3-methylcholanthrene.
* Supported in part by NIH Grant CA 02590.
Received 5/18/64.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |